Application of Artificial Intelligence in Precision Medicine and Healthcare

June 3, 2025 updated by: Yi Ting Yeh

Application of Artificial Intelligence to Construct Whole-person Precise Smart Medicine and Precise Health Care Program in Patients With Myasthenia Gravis

This study aims to propose an intelligent health robot that utilizes remote intelligent robots to assist patients with disease-related issues, enabling them to address their problems promptly.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Utilizing an information architecture system, a voice-based artificial intelligence program will be developed. The symptoms of major diseases and related knowledge will be input into this system to construct a dedicated disease platform. This platform will allow patients to remotely access it, enabling them to promptly understand and address disease-related issues, thereby improving convenience for patients.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
    • Tamsui District
      • New Taipei City, Tamsui District, Taiwan, 251
        • Recruiting
        • Yi Ting Yeh
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients diagnosed with myasthenia gravis by a physician.
  2. Age 20 years and above.
  3. Able to use a smartphone.

Exclusion Criteria:

  1. Individuals not diagnosed with myasthenia gravis.
  2. Individuals who do not use smartphones or tablets.
  3. Individuals who withdraw from the group midway.
  4. Individuals unwilling to participate in interviews.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Disease Group
In this study, patients with myasthenia gravis will be used as an example. After the patients use this disease inquiry platform, researchers will conduct interviews with them to understand their experiences and feedback.
Device: Mobile device.(phone)
Develop a mobile device [Disease Assistance Consultation] to help patients promptly understand their disease and how to care for it. After a 4-week trial period, conduct interviews with participants to determine whether using the mobile device can increase participants' knowledge and improve the quality of healthcare.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Can the use of a mobile device [Disease Assistance Consultation] enhance the understanding of disease care and increase knowledge related to diseases in traditional Chinese medicine?
Time Frame: 4 weeks
Each patient will be followed up after using the application system for 4 weeks. Each patient will be interviewed for 20 minutes, and the data will be compiled and written later.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yi Ting Yeh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2023

Primary Completion (Estimated)

April 19, 2026

Study Completion (Estimated)

July 19, 2026

Study Registration Dates

First Submitted

August 10, 2024

First Submitted That Met QC Criteria

March 13, 2025

First Posted (Actual)

March 17, 2025

Study Record Updates

Last Update Posted (Actual)

June 4, 2025

Last Update Submitted That Met QC Criteria

June 3, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20221210R

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myasthenia Gravis

Clinical Trials on Mobile device.(phone)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe